Ledger.Open graph →
SEC Form D · Amendment · filed July 8, 2025

Paragon Biosciences Emalex Capital, Inc

Offering
$270.0M
Sold
$270.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHICACO, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Eric J. Messner · Chicago, ILExec · DirectorAntonio J. Gracias · Chicago, ILDirectorRicky J. Sun · Chicago, ILDirectorPatrick J. Morris · Chicago, ILExecJeffrey J. Aronin · Chicago, ILDirectorDarien J. Parhad · Chicago, ILExecJeffrey J. Dayno · Chicago, ILDirectorRicky J. Sun · Chicago, ILDirectorPatrick N. Nolan · Atlanta, GADirectorEric J. Messner · Chicago, ILExec · DirectorWilliam D. Rahm · New York, NYExecRicardo Lombardi · New York, NYDirectorAmit Assaraf · New York, NYExecJeffrey J. Dayno · Chicago, ILDirectorKevin Chavers · New York, NYDirectorAl C. Laskaj · NEW YORK, NYDirectorDana C. Devivo · NEW YORK, NYExecFrancis C. Poli · NEW YORK, NYExecJames L. Alt · New York, NYExec · DirectorMichael L. Appel · New York, NYDirectorDavid Tingley · Naples, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗